<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://patholines.org/index.php?action=history&amp;feed=atom&amp;title=Invasive_squamous_cell_carcinoma_of_the_cervix</id>
	<title>Invasive squamous cell carcinoma of the cervix - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://patholines.org/index.php?action=history&amp;feed=atom&amp;title=Invasive_squamous_cell_carcinoma_of_the_cervix"/>
	<link rel="alternate" type="text/html" href="https://patholines.org/index.php?title=Invasive_squamous_cell_carcinoma_of_the_cervix&amp;action=history"/>
	<updated>2026-08-20T16:29:42Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://patholines.org/index.php?title=Invasive_squamous_cell_carcinoma_of_the_cervix&amp;diff=6616&amp;oldid=prev</id>
		<title>Mikael Häggström: Started</title>
		<link rel="alternate" type="text/html" href="https://patholines.org/index.php?title=Invasive_squamous_cell_carcinoma_of_the_cervix&amp;diff=6616&amp;oldid=prev"/>
		<updated>2022-12-22T00:32:45Z</updated>

		<summary type="html">&lt;p&gt;Started&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{Top&lt;br /&gt;
|author1=[[User:Mikael Häggström|Mikael Häggström]]&lt;br /&gt;
|author2=&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/noinclude&amp;gt;&lt;br /&gt;
==Microscopic evaluation==&lt;br /&gt;
Infiltration as irregular anastomosing nests or single cells.&amp;lt;ref&amp;gt;{{cite web|url=https://www.pathologyoutlines.com/topic/cervixscc.html|title=Cervix - Squamous cell carcinoma and variants|website=Pathology Outlines|author=Author: Gulisa Turashvili, M.D., Ph.D.}} Last author update: 24 September 2020. Last staff update: 13 December 2022&amp;lt;/ref&amp;gt; In contrast to tangentially cut projections of glands involved by HSIL, the invasive nests of tumor cells are irregular and accompanied by a distinct stromal reaction of edema and chronic inflammatory cells.&lt;br /&gt;
&amp;lt;gallery mode=packed heights=210&amp;gt;&lt;br /&gt;
File:Histopathology of squamous cell carcinoma of the cervix.png|&amp;#039;&amp;#039;&amp;#039;Invasive SCC of the cervix&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
File:Invasive Squamous Carcinoma of the Cervix. Cold Knife Cone (6076190079).jpg|&amp;#039;&amp;#039;&amp;#039;Invasive SCC of the cervix&amp;#039;&amp;#039;&amp;#039;&amp;lt;ref group=image&amp;gt;[https://commons.wikimedia.org/wiki/File:Invasive_Squamous_Carcinoma_of_the_Cervix._Cold_Knife_Cone_(6076190079).jpg Invasive Squamous Carcinoma of the Cervix. Cold Knife Cone (6076190079).jpg] by Ed Uthman, MD. {{CC-BY 2.0 inline}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Staging==&lt;br /&gt;
As per AJCC 9:&amp;lt;ref name=&amp;quot;pmid33784415&amp;quot;&amp;gt;{{cite journal| author=Olawaiye AB, Baker TP, Washington MK, Mutch DG| title=The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. | journal=CA Cancer J Clin | year= 2021 | volume= 71 | issue= 4 | pages= 287-298 | pmid=33784415 | doi=10.3322/caac.21663 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=33784415  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; &lt;br /&gt;
|-&lt;br /&gt;
! T CATEGORY&lt;br /&gt;
! FIGO STAGE&lt;br /&gt;
! T CRITERIA&lt;br /&gt;
|-&lt;br /&gt;
| TX&lt;br /&gt;
| Primary tumor cannot be assessed&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| T0&lt;br /&gt;
| No evidence of primary tumor&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| T1&lt;br /&gt;
| I&lt;br /&gt;
| Carcinoma is strictly confined to the cervix (extension to the corpus should be disregarded)&lt;br /&gt;
|-&lt;br /&gt;
| T1a&lt;br /&gt;
| IA&lt;br /&gt;
| Invasive carcinoma that can be diagnosed only by microscopy with maximum depth of invasion ≤5 mm&lt;br /&gt;
|-&lt;br /&gt;
| T1a1&lt;br /&gt;
| IA1&lt;br /&gt;
| Measured stromal invasion ≤3 mm in depth&lt;br /&gt;
|-&lt;br /&gt;
| T1a2&lt;br /&gt;
| IA2&lt;br /&gt;
| Measured stromal invasion &amp;gt;3 mm and ≤5 mm in depth&lt;br /&gt;
|-&lt;br /&gt;
| T1b&lt;br /&gt;
| IB&lt;br /&gt;
| Invasive carcinoma with measured deepest invasion &amp;gt;5 mm (greater than stage IA); lesion limited to the cervix uteri with size measured by maximum tumor diameter; note: the involvement of vascular/lymphatic spaces should not change the staging, and the lateral extent of the lesion is no longer considered&lt;br /&gt;
|-&lt;br /&gt;
| T1b1&lt;br /&gt;
| IB1&lt;br /&gt;
| Invasive carcinoma &amp;gt;5 mm depth of stromal invasion and ≤2 cm in greatest dimension&lt;br /&gt;
|-&lt;br /&gt;
| T1b2&lt;br /&gt;
| IB2&lt;br /&gt;
| Invasive carcinoma &amp;gt;2 cm and ≤4 cm in greatest dimension&lt;br /&gt;
|-&lt;br /&gt;
| T1b3&lt;br /&gt;
| IB3&lt;br /&gt;
| Invasive carcinoma &amp;gt;4 cm in greatest dimension&lt;br /&gt;
|-&lt;br /&gt;
| T2&lt;br /&gt;
| II&lt;br /&gt;
| Carcinoma invades beyond the uterus but has not extended onto the lower one-third of the vagina or to the pelvic wall&lt;br /&gt;
|-&lt;br /&gt;
| T2a&lt;br /&gt;
| IIA&lt;br /&gt;
| Involvement limited to the upper two-thirds of the vagina without parametrial invasion&lt;br /&gt;
|-&lt;br /&gt;
| T2a1&lt;br /&gt;
| IIA1&lt;br /&gt;
| Invasive carcinoma ≤4 cm in greatest dimension&lt;br /&gt;
|-&lt;br /&gt;
| T2a2&lt;br /&gt;
| IIA2&lt;br /&gt;
| Invasive carcinoma &amp;gt;4 cm in greatest dimension&lt;br /&gt;
|-&lt;br /&gt;
| T2b&lt;br /&gt;
| IIB&lt;br /&gt;
| With parametrial invasion but not up to the pelvic wall&lt;br /&gt;
|-&lt;br /&gt;
| T3&lt;br /&gt;
| III&lt;br /&gt;
| Carcinoma involves the lower one-third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney; note: the pelvic wall is defined as the muscle, fascia, neurovascular structures, and skeletal portions of the bony pelvis; cases with no cancer-free space between the tumor and pelvic wall by rectal examination are FIGO stage III&lt;br /&gt;
|-&lt;br /&gt;
| T3a&lt;br /&gt;
| IIIA&lt;br /&gt;
| Carcinoma involves the lower one-third of the vagina, with no extension to the pelvic wall&lt;br /&gt;
|-&lt;br /&gt;
| T3b&lt;br /&gt;
| IIIB&lt;br /&gt;
| Extension to the pelvic wall and/or hydronephrosis or nonfunctioning kidney (unless known to be due to another cause)&lt;br /&gt;
|-&lt;br /&gt;
| T4&lt;br /&gt;
| IVA&lt;br /&gt;
| Carcinoma has involved (biopsy-proven) the mucosa of the bladder or rectum or has spread to adjacent organs (bullous edema, as such, does not permit a case to be assigned to stage IVA)&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Microscopy report===&lt;br /&gt;
Example:&lt;br /&gt;
{|class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
| Cervix, uterus, bilateral tubes, ovaries and parametria,&amp;lt;br&amp;gt;hysterectomy and bilateral salpingo-oophorectomy:&lt;br /&gt;
*Residual squamous cell carcinoma on anterior cervix, 3 mm in greatest dimension, with up to 2 mm invasion, with associated biopsy site changes, and high-grade squamous intraepithelial lesion (CIN III).&lt;br /&gt;
*Inactive endometrium&lt;br /&gt;
&lt;br /&gt;
SYNOPTIC REPORT:&amp;lt;br&amp;gt;Based on Hysterectomy (current specimen) and previous cone biopsy:&lt;br /&gt;
*Procedure: Cone (previous procedure) and hysterectomy with bilateral salpingo-oophorectomy&lt;br /&gt;
*Tumor site: Anterior cervix&lt;br /&gt;
*Histologic type: Squamous cell carcinoma, HPV-associated&lt;br /&gt;
*Histologic grade: G2, moderately differentiated (based on current hysterectomy and previous cone biopsy&lt;br /&gt;
*Tumor size: Estimated tumor size is 2.6 cm in greatest dimension (based on previous cone biopsy)&lt;br /&gt;
*Depth of stromal invasion: 7 mm (based on previous cone biopsy)&lt;br /&gt;
*Lymphovascular invasion: Present (based on previous cone biopsy)&lt;br /&gt;
*Margin(s): Negative for invasive carcinoma&lt;br /&gt;
*Additional Findings: &lt;br /&gt;
:*High-grade squamous intraepithelial lesion (CIN 3)&lt;br /&gt;
:*Previous biopsy site changes&lt;br /&gt;
*p16 Immunohistochemistry: Positive (based on the previous cone biopsy)&lt;br /&gt;
*Pathologic stage: pT1b2, Invasive carcinoma greater than 2 cm and less than or equal to 4 cm in greatest dimension (based on current specimen and previous cone biopsy)&lt;br /&gt;
* FIGO Stage: IB2&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;noinclude&amp;gt;{{Bottom}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;</summary>
		<author><name>Mikael Häggström</name></author>
	</entry>
</feed>